LTFS
MCRB icon

Ladenburg Thalmann Financial Services’s Seres Therapeutics MCRB Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3K Hold
50
– – ﹤0.01% 4966
2019
Q3 		$4K Hold
50
– – ﹤0.01% 4774
2019
Q2 		$3K Hold
50
– – ﹤0.01% 4880
2019
Q1 		$7K Hold
50
– – ﹤0.01% 4533
2018
Q4 		$5K Sell
50
-125
-71% -$17.5K ﹤0.01% 4597
2018
Q3 		$27K Buy
175
+100
+133% +$16.2K ﹤0.01% 3716
2018
Q2 		$11K Hold
75
– – ﹤0.01% 4197
2018
Q1 		$11K Sell
75
-55
-42% -$10.5K ﹤0.01% 4197
2017
Q4 		$26K Buy
130
+25
+24% +$5.14K ﹤0.01% 3623
2017
Q3 		$34K Buy
105
+10
+11% +$2.73K ﹤0.01% 3355
2017
Q2 		$21K Buy
95
+50
+111% +$10.3K ﹤0.01% 3585
2017
Q1 		$10K Hold
45
– – ﹤0.01% 3983
2016
Q4 		$9K Hold
45
– – ﹤0.01% 3957
2016
Q3 		$11K Buy
45
+25
+125% +$8.77K ﹤0.01% 3760
2016
Q2 		$12K Buy
20
+5
+33% +$2.93K ﹤0.01% 3663
2016
Q1 		$8K Buy
+15
New +$7.83K ﹤0.01% 3836

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ladenburg Thalmann Financial Services's MCRB Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Seres Therapeutics (MCRB) position steady in Q4 2019 at 50 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4966.

Ladenburg Thalmann Financial Services first reported a position in MCRB in Q1 2016 and has held it in 16 quarters since. The position peaked at $34K in Q3 2017. 79 funds tracked by Wall St. Rank hold MCRB as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 50 shares of Seres Therapeutics worth $3K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Seres Therapeutics share count unchanged in Q4 2019.
  • Seres Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4966 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Seres Therapeutics in Q1 2016 and has held it in 16 quarters since.
  • Ladenburg Thalmann Financial Services's Seres Therapeutics position peaked at $34K in Q3 2017.
  • 79 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.